Roth Capital Starts Inotek Pharmaceuticals (ITEK) at Buy

December 1, 2016 9:07 AM EST
Get Alerts ITEK Hot Sheet
Price: $6.80 -2.16%

Rating Summary:
    5 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 21 | Down: 36 | New: 11
Trade ITEK Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Roth Capital initiated coverage on Inotek Pharmaceuticals (NASDAQ: ITEK) with a Buy rating and a price target of $10.

For an analyst ratings summary and ratings history on Inotek Pharmaceuticals click here. For more ratings news on Inotek Pharmaceuticals click here.

Shares of Inotek Pharmaceuticals closed at $6.40 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

New Coverage

Related Entities

Roth Capital

Add Your Comment